{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:16:11Z","timestamp":1761920171539,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.msard.2016.07.012","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T09:40:33Z","timestamp":1469526033000},"page":"122-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Three cases of herpes zoster radiculitis in MS patients treated with natalizumab"],"prefix":"10.1016","volume":"9","author":[{"given":"Bassem I.","family":"Yamout","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuhad","family":"Abou Zeid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali J.","family":"Taha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya M.","family":"Zeineddine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samia J.","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2016.07.012_bib1","unstructured":"Biogen Idec, 2016. PML-Inzidenz unter Tysabri\u00ae nach Marktzulassung. Patientenregister, ww.tpysabri.de."},{"key":"10.1016\/j.msard.2016.07.012_bib2","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMoa1107829","article-title":"Risk of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"366","author":"Bloomgren","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2016.07.012_bib3","doi-asserted-by":"crossref","first-page":"24655","DOI":"10.1016\/S0021-9258(19)74516-5","article-title":"VLA-4 integrin mediates lymphocyte migration on the inducible endothelial cell ligand VCAM-1 and the extracellular matrix ligand fibronectin","volume":"268","author":"Chan","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.msard.2016.07.012_bib4","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/cid\/cit376","article-title":"Central nervous system herpes simplex and varicella zoster virus infections in natalizumab-treated patients","volume":"57","author":"Fine","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.msard.2016.07.012_bib5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/cns.12067","article-title":"Report of three cases of herpes zoster during treatment with natalizumab","volume":"19","author":"Fragoso","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.msard.2016.07.012_bib6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.0105-2896.2005.00240.x","article-title":"Multiple sclerosis","volume":"204","author":"Hafler","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.msard.2016.07.012_bib7","first-page":"e004833","article-title":"Systematic review of incidence and complications of herpes zoster: Towards a global perspective","volume":"4","author":"Kawai","year":"2014","journal-title":"Br. Med. J. Open"},{"key":"10.1016\/j.msard.2016.07.012_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1742-2094-11-19","article-title":"Varicella zoster-associated retinal and central nervous system vasculitis in a patient with multiple sclerosis treated with natalizumab","volume":"11","author":"Kobeleva","year":"2014","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.msard.2016.07.012_bib9","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1177\/1352458515576984","article-title":"Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis","volume":"14","author":"Kohlmann","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2016.07.012_bib10","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1177\/1352458511428082","article-title":"Herpes encephalitis during natalizumab treatment in multiple sclerosis","volume":"18","author":"Kwiatkowski","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2016.07.012_bib11","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nri2156","article-title":"Getting to the site of inflammation: the leukocyte adhesion cascade updated","volume":"7","author":"Ley","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.msard.2016.07.012_bib12","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1056\/NEJMoa044397","article-title":"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis","volume":"354","author":"Polman","year":"2006","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.msard.2016.07.012_bib13","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1212\/WNL.0b013e3182735d00","article-title":"Varicella zoster virus encephalitis and vasculopathy in a patient treated with fingolimod","volume":"79","author":"Ratchford","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2016.07.012_bib14","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1212\/01.WNL.0000158329.30470.D0","article-title":"Anti-alpha4 integrin therapy for multiple sclerosis: mechanisms and rationale","volume":"64","author":"Rice","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2016.07.012_bib15","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa044396","article-title":"Natalizumab plus interferon beta-1a for relapsing multiple sclerosis","volume":"354","author":"Rudick","year":"2006","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.msard.2016.07.012_bib16","unstructured":"Scheiss, N., Zong, J., Hayward, G., Calabresi, P., et al., 2009. Reactivation of Herpes Virus in Multiple Sclerosis Patients on Natalizumab Therapy [P03.163]. Poster Presentation, April 29 at the American Academy of Neurology Congress."},{"key":"10.1016\/j.msard.2016.07.012_bib17","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s13365-011-0027-4","article-title":"Natalizumab and HSV meningitis","volume":"17","author":"Shenoy","year":"2011","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.msard.2016.07.012_bib18","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ana.20858","article-title":"Immune surveillance in multiple sclerosis patients treated with natalizumab","volume":"59","author":"Stuve","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2016.07.012_bib19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/rmv.710","article-title":"Progressive multifocal leukoencephalopathy: clinical and molecular aspects","volume":"22","author":"Tavazzi","year":"2012","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.msard.2016.07.012_bib20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0264-410X(01)00276-6","article-title":"Seroprevalence of varicella-zoster virus in the German population","volume":"20","author":"Wutzler","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.msard.2016.07.012_bib21","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1212\/WNL.0b013e3182918d27","article-title":"Varicella-zoster virus acute myelitis in a patient with MS treated with natalizumab","volume":"80","author":"Yeung","year":"2013","journal-title":"Neurology"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034816301213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034816301213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:39:00Z","timestamp":1761899940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034816301213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":21,"alternative-id":["S2211034816301213"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2016.07.012","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Three cases of herpes zoster radiculitis in MS patients treated with natalizumab","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2016.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}